Published by Coherent Market Insights
Posted on September 20, 2021
Pigmented lesion is a skin disease usually referred to as melanocytic proliferations. Pigmented lesions are brown, black or blue in color due to melanin, blood, or exogenous pigment. Spreading or growing lesions, pigmented lesions on exposed skin can be a symptom of skin cancer. Pigmented lesion are classified as non-melanocytic lesions and melanocytic lesions, and further classified as benign and malignant. Malignant lesion is a tissue, which appears abnormal under microscopic examination, and is more likely to be cancer tissue. Thus, removal of premalignant lesion reduces proliferation and occurrence of malignant skin diseases. Early diagnosis and complete removal of lesions can prevent occurrence of all types of skin cancers. Factors for pigment lesion are natural and environmental that includes, photodamage, which is caused due to constant exposure to ultraviolet (UV) radiation that leads to skin problems and early skin aging. Almost all age group population are susceptible to pigment lesion. There are wide range of laser treatments available for pigmented lesion such as ErYAG, MedLite laser, which are effective and relatively affordable.
Increasing laser systems for treatment of pigmented lesion is expected to fuel growth of the pigmented lesion treatment market
Manufacturers are focusing on innovation to deliver new and advanced treatment options for pigmented lesion. For instance, in 2014, Syneron Medical Ltd. launched PicoWay picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam for pigmented lesion treatment and tattoo removal. PicoWay is a dual wavelength device, with 532nm and 1064nm wavelength. Furthermore, in 2014, Lutronic Corporation launched Lutronic XT Q-Switched, frequency doubled Nd:YAG laser known as the Spectra XT, the system includes several treatment application such as pigmented lesion, tattoo removal, melisma, pore-size reduction, and skin-rejuvenation.
Request for Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/1089
Cutera, Inc. introduced two new laser systems at the 72nd American Academy of Dermatology conference, 2014 in the U.S. Both the lasers, named excel HR and Enlighten are targeted for hair removal, tattoo removal, and benign pigmented lesion. In 2016, Cynosure received the U.S. FDA clearance to market PicoSure Energy delivery system for tattoos and pigmented lesions.
Pigmented Lesion Treatment Market taxonomy
By Laser Type:
By Indication Type:
By End User
Asia Pacific is expected to witness significant growth in the pigmented lesion treatment market over the forecast period
On the basis of region, the global pigmented lesion treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest market share, followed by Europe and Asia Pacific, respectively over the forecast period. Growth of the pigmented lesion treatment market in North America is driven by factors such as increasing aesthetic awareness among populace and growing prevalence of pigmented lesion in the region. For instance, according to the Skin Cancer Foundation, over 5.4 million cases of non-melanoma skin cancer are reported in the U.S. annually and over 3.3 million people receive treatment, which in turn favors growth of pigmented lesion treatment market in North America. Pigmented lesion treatment market in Asia Pacific is expected to witness significant growth, owing to factors such as increasing government support for treatment of lesion. For instance, the New South Wales (NSW) Government selected 12 innovative tech start-ups to exhibit at CeBIT Australia. Among these companies, Dermaspec, which is a high-quality, color calibrated low-cost camera for dermatoscopic imaging of pigmented skin lesions at a modest cost, which in turn will favor the growth of pigmented lesion market in Asia Pacific region.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/169
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Increasing competition in the product space is driving innovation in treatment systems, which is expected to fuel growth of the global pigmented lesion treatment market
In September 2017, Fotona, a company based in the U.S. and Europe received the U.S. FDA clearance for its new StarWalker MaQX Q-Switched laser system for treating tattoos, pigmented and vascular lesions, acne and scar revision, and even for permanent hair reduction. Such constant product approval increases the competition between key market players in pigmented lesion treatment market.
Key players operating in the global market of pigmented lesion treatment market include Lutronic Corporation, Fotona d.d., Alma Lasers, Ltd., EL.En. S.p.A., Solta Medical Inc., Cynosure, Inc., Syneron Medical Ltd., Sciton, Inc., Cutera Inc., Lumenis Ltd., Strata Skin Sciences, Inc., and Lynton Lasers Ltd.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Pigmented Lesion Treatment Market Report Shows Increasing Demand Due to the High Adoption and Changing Consumer Dynamics appeared first on Gatorledger.
Pigmented lesion is a skin disease usually referred to as melanocytic proliferations. Pigmented lesions are brown, black or blue in color due to melanin, blood, or exogenous pigment. Spreading or growing lesions, pigmented lesions on exposed skin can be a symptom of skin cancer. Pigmented lesion are classified as non-melanocytic lesions and melanocytic lesions, and further classified as benign and malignant. Malignant lesion is a tissue, which appears abnormal under microscopic examination, and is more likely to be cancer tissue. Thus, removal of premalignant lesion reduces proliferation and occurrence of malignant skin diseases. Early diagnosis and complete removal of lesions can prevent occurrence of all types of skin cancers. Factors for pigment lesion are natural and environmental that includes, photodamage, which is caused due to constant exposure to ultraviolet (UV) radiation that leads to skin problems and early skin aging. Almost all age group population are susceptible to pigment lesion. There are wide range of laser treatments available for pigmented lesion such as ErYAG, MedLite laser, which are effective and relatively affordable.
Increasing laser systems for treatment of pigmented lesion is expected to fuel growth of the pigmented lesion treatment market
Manufacturers are focusing on innovation to deliver new and advanced treatment options for pigmented lesion. For instance, in 2014, Syneron Medical Ltd. launched PicoWay picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam for pigmented lesion treatment and tattoo removal. PicoWay is a dual wavelength device, with 532nm and 1064nm wavelength. Furthermore, in 2014, Lutronic Corporation launched Lutronic XT Q-Switched, frequency doubled Nd:YAG laser known as the Spectra XT, the system includes several treatment application such as pigmented lesion, tattoo removal, melisma, pore-size reduction, and skin-rejuvenation.
Request for Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/1089
Cutera, Inc. introduced two new laser systems at the 72nd American Academy of Dermatology conference, 2014 in the U.S. Both the lasers, named excel HR and Enlighten are targeted for hair removal, tattoo removal, and benign pigmented lesion. In 2016, Cynosure received the U.S. FDA clearance to market PicoSure Energy delivery system for tattoos and pigmented lesions.
Pigmented Lesion Treatment Market taxonomy
By Laser Type:
By Indication Type:
By End User
Asia Pacific is expected to witness significant growth in the pigmented lesion treatment market over the forecast period
On the basis of region, the global pigmented lesion treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest market share, followed by Europe and Asia Pacific, respectively over the forecast period. Growth of the pigmented lesion treatment market in North America is driven by factors such as increasing aesthetic awareness among populace and growing prevalence of pigmented lesion in the region. For instance, according to the Skin Cancer Foundation, over 5.4 million cases of non-melanoma skin cancer are reported in the U.S. annually and over 3.3 million people receive treatment, which in turn favors growth of pigmented lesion treatment market in North America. Pigmented lesion treatment market in Asia Pacific is expected to witness significant growth, owing to factors such as increasing government support for treatment of lesion. For instance, the New South Wales (NSW) Government selected 12 innovative tech start-ups to exhibit at CeBIT Australia. Among these companies, Dermaspec, which is a high-quality, color calibrated low-cost camera for dermatoscopic imaging of pigmented skin lesions at a modest cost, which in turn will favor the growth of pigmented lesion market in Asia Pacific region.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/169
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Increasing competition in the product space is driving innovation in treatment systems, which is expected to fuel growth of the global pigmented lesion treatment market
In September 2017, Fotona, a company based in the U.S. and Europe received the U.S. FDA clearance for its new StarWalker MaQX Q-Switched laser system for treating tattoos, pigmented and vascular lesions, acne and scar revision, and even for permanent hair reduction. Such constant product approval increases the competition between key market players in pigmented lesion treatment market.
Key players operating in the global market of pigmented lesion treatment market include Lutronic Corporation, Fotona d.d., Alma Lasers, Ltd., EL.En. S.p.A., Solta Medical Inc., Cynosure, Inc., Syneron Medical Ltd., Sciton, Inc., Cutera Inc., Lumenis Ltd., Strata Skin Sciences, Inc., and Lynton Lasers Ltd.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Pigmented Lesion Treatment Market Report Shows Increasing Demand Due to the High Adoption and Changing Consumer Dynamics appeared first on Gatorledger.
Explore more articles in the Research Reports category
